Glenmark#39;s partner Elite gets USFDA nod for opioid analgesic drug

Glenmark#39;s partner Elite gets USFDA nod for opioid analgesic drug The abbreviated new drug application (ANDA) approval by the United States Food and Drug Administration (USFDA) is for the tablets in the strengths of 5 mg and 10 mg, Glenmark said in a statement.

No comments:

Post a Comment